Simplex Trading
ACHN

Simplex Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

Simplex Trading’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-413
Closed -$249K – 8702
2019
Q4 		$249K Buy
413
+172
+71% +$996 ﹤0.01% 3518
2019
Q3 		$86K Buy
+241
New +$929 ﹤0.01% 4482
2018
Q4 		– Sell
-100
Closed -$36K – 8281
2018
Q3 		$36K Buy
+100
New +$298 ﹤0.01% 5489
2017
Q4 		– Sell
-29
Closed -$1K – 7080
2017
Q3 		$1K Buy
+29
New +$129 ﹤0.01% 5692
2017
Q1 		– Sell
-5
Closed -$1K – 7121
2016
Q4 		$1K Sell
5
-8
-62% -$43 ﹤0.01% 5640
2016
Q3 		$1K Sell
13
-19
-59% -$162 ﹤0.01% 5558
2016
Q2 		$7K Sell
32
-24
-43% -$206 ﹤0.01% 3987
2016
Q1 		$12K Sell
56
-265
-83% -$1.94K ﹤0.01% 3348
2015
Q4 		$15K Buy
321
+29
+10% +$264 ﹤0.01% 2984
2015
Q3 		$56K Buy
292
+238
+441% +$1.94K ﹤0.01% 1901
2015
Q2 		$4K Sell
54
-85
-61% -$804 ﹤0.01% 3927
2015
Q1 		$27K Sell
139
-1,321
-90% -$16.5K ﹤0.01% 2087
2014
Q4 		$322K Buy
+1,460
New +$17.8K 0.04% 402

Simplex Trading's ACHN Position: Q1 2020 in Review

Simplex Trading sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 600 shares — an estimated $3K sold.

Simplex Trading first reported a position in ACHN in Q4 2014 and held it in 14 quarters. The position peaked at $300K in Q4 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Simplex Trading reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Simplex Trading sold 600 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3K.
  • Simplex Trading first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 14 quarters.
  • Simplex Trading's Achillion Pharmaceuticals position peaked at $300K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.